About Mubadala Healthcare

Mubadala Healthcare, a division of Mubadala Development Company, is specifically dedicated to investment in strategic, high value and economically sustainable projects that meaningfully enhance the private healthcare infrastructure of Abu Dhabi and the UAE.

Mubadala Healthcare’s investment focus includes patient care delivery and ancillary services, biotechnology, medical equipment and device manufacturing and pharmaceuticals. In line with Mubadala Development Company’s vision and mission, we evaluate potential projects on both their likely commercial returns as well as on their socio-economic impact, with a view to making substantial contributions to the quality of life in Abu Dhabi and the UAE.

In our healthcare services investments, we aim to provide the highest international standards of care and superior clinical outcomes for patients in Abu Dhabi and the UAE. A key objective is to address the needs of patients currently traveling abroad for treatment. Our goal is to create a robust and fully integrated private healthcare infrastructure in Abu Dhabi, designed around the needs of the patient and with an absolute commitment to quality.

Working with best-in-class clinical operating partners from around the world, Mubadala Healthcare is actively investing in carefully chosen projects in order to achieve this objective.

Together, these projects will form a vertically integrated healthcare delivery network that is supported by state-of-the-art IT systems and medical technologies to provide a seamless and high quality patient experience.

As well as improved healthcare, wellbeing and productivity, this new healthcare infrastructure will also encompass further economic diversification and job opportunities for the Emirate’s people.

Other healthcare projects include:

Cleveland Clinic Abu Dhabi a state-of-the-art 360-bed Cleveland Clinic hospital, scheduled to open in 2012.

Imperial College London Diabetes Centre a centre of excellence specializing in diabetes treatment, research, training and education; opened in 2006.

Abu Dhabi Knee & Sports Medicine Centre the first healthcare facility in the Middle East to specialize in the diagnosis and treatment of patients with knee and sports-related injuries; opened in 2006.

Tawam Molecular Imaging Centre a specialist molecular imaging facility including PET-CT and Cyclotron, managed by Johns Hopkins Medicine International. It is due to open on the Tawam Hospital campus in Al Ain city in early 2010.

National Reference Lab a fully automated reference laboratory, managed by Laboratory Corporation of America (LabCorp), that will serve both public and private health providers in Abu Dhabi and the UAE. Set to revolutionize laboratory testing in the UAE, it is due to open in early 2010.

Arzanah Wellness & Diagnostic Centre a multi-specialty facility operated by Singapore’s AsiaMedic Limited. It will provide a range of medical specialties as well as advanced diagnostic imaging. It will be located at the Arzanah Medical Complex and is due to open in 2011.

Wooridul Spine Centre a state-of-the-art facility dedicated to the provision of diagnostic and therapeutic services to spine injury patients, based on a minimally invasive treatment principle. The Centre will be operated by Korean spine specialists, Wooridul, and is scheduled to open at the Arzanah Medical Complex in 2011.